Durvalumab with or Without Bevacizumab with Transarterial Chemoembolisation in Hepatocellular Carcinoma (EMERALD-1): A Multiregional, Randomised, Double-blind, Placebo-controlled, Phase 3 Study
Sangro, Bruno, Kudo, Masatoshi, Erinjeri, Joseph P, Qin, Shukui, Ren, Zhenggang, Chan, Stephen L, Arai, Yasuaki, Heo, Jeong, Mai, Anh, Escobar, Jose, Lopez Chuken, Yamil Alonso, Yoon, Jung-Hwan, Tak, Won Young, Breder, Valeriy V, Suttichaimongkol, Tanita, Bouattour, Mohamed, Lin, Shi-Ming, Peron, Jean-Marie, Nguyen, Quang T, Yan, Lunan, Chiu, Chang-Fang, Santos, Florinda A, Veluvolu, Anil, Thungappa, Satheesh Chiradoni, Matos, Marco, Żotkiewicz, Magdalena, Udoye, Stephanie I, Kurland, John F, Cohen, Gordon J, Lencioni, Riccardo, Abdalla, Kathia, Allaire, Manon, Alves, Gustavo, Antunes, Luis, Assenat, Eric, Azevedo, Sergio, Barreto, Rafael, Beg, Muhammad, Bertollo, Glaucio, Blanc, Jean-Frederic, Boya, Rakesh Reddy, Valery, Bronowicki, Jean-Pierre, Buranachokphaisan, Manoch, Burgoyne, Adam, Stephen, Chang, Ting-Tsung, Chao, Yee, Chen, Xiaoming, Choi, Minsig, Sunghee, Coburn, Natalie, Contreras, Dayyani, Farshid, Decaens, Thomas, Dechaphunkul, Arunee, del Consuelo Diaz, Maria, Dev, Anouk, Dutra, Jamille, Eastgate, Melissa, Estfan, Bassam, Ferrari, Vittorio, Frin, Anne-Claire, Ganguly, Sandip, Ganta, Ranga Raman, Gu, Shanzhi, Guo, Yabing, Hagihara, Atsushi, Hsu, Chih-Hung, Hwang, Jimmy, Inaba, Yoshitaka, Jain, Shikha, Jonker, Derek, K, Rajeev L, Kat
pdfen2025
